EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Effects of a Sea-Level Stay on Pulmonary Hemodynamics in Patients With Pulmonary Arterial Hypertension Living in Quito Near 2,850 m

Silvia Ulrich, Julian Müller, Michael Furian, Stéphanie Saxer, Simon R Schneider, Joel Herzig, Meret Bauer, Mirjam Schmucki, Diego Saragoni, Laura Mayer, Esther I Schwarz, Elizabeth Cajamarca und 2 weitere

CHEST · 2026-08 · 170 (2) · 512-523

DOI: 10.1016/j.chest.2026.02.043 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift CHEST, 2026-08. Verfasst von Silvia Ulrich und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electroni…. Hauptthemen laut MEDLINE: Altitude, Hemodynamics, Hypertension, Pulmonary, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Among the > 80 million people living > 2,500 m are patients with pulmonary arterial hypertension (PAH). RESEARCH QUESTION: How does descent to sea level (SL) affect pulmonary hemodynamics and 6-minute walk distance (6MWD) in patients with PAH living at high altitude (HA)? STUDY DESIGN AND METHODS: HA residents with PAH were transported to SL. Vital signs including heart rate (HR), arterial oxygen saturation (Sao2), 6MWD, systolic pulmonary artery pressure (sPAP), cardiac output (CO), and other measures were assessed at 2,850 m and after the first night (day 2) and second night (day 3) at SL. RESULTS: Twenty-eight patients (24 female; age, 46 ± 12 y), treated with phosphodiesterase type 5 inhibitors (n = 28) and endothelin receptor antagonists (n = 9), were included. Sao2, sPAP, HR, CO, and 6MWD at HA were 90% ± 5%, 68 ± 24 mm Hg, 74 ± 14 bpm, 3.9 ± 1.1 L/min, and 462 ± 100 m. On SL day 2, Sao2 was higher (+5.5% [3.9%-7.1%], sPAP and HR were lower (-11 [-16 to -5] mm Hg and -7 [-12 to -3] bpm) (all P < .001), resulting in unchanged sPAP/CO and oxygen delivery. HR and CO further decreased on day 3, resulting in unchanged sPAP/CO vs HA. 6MWD was higher at SL vs HA on day 2 (+41 [16-67] m; P < .001) but not day 3. No adverse events occurred, including after re-ascent. INTERPRETATION: Our results show that typical patients with PAH living at 2,850 m reveal improved blood oxygenation after descent to SL along with decreased sPAP, but also HR, resulting in unchanged pulmonary resistance and oxygen delivery. Although 6MWD initially increased at SL, it returned to high-altitude baseline after the second night, along with further HR and CO decrease. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; Nos.: NCT06092424, NCT05996302; URL: www. CLINICALTRIALS: gov.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AltitudeHemodynamicsHypertension, PulmonaryPulmonary Arterial HypertensionAdultFemaleHumansMaleMiddle AgedCardiac OutputEndothelin Receptor AntagonistsHeart RateOxygen SaturationPhosphodiesterase 5 InhibitorsWalk Test

Stichwörter der Autor:innen

echocardiographyhigh-altitude dwellerspulmonary arterial hypertension

Substanzen

Endothelin Receptor AntagonistsPhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electronic address: silvia.ulrich@usz.ch.
  • Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Health, Eastern Swiss University of Applied Sciences St. Gallen,…
  • Pneumology Unit Quito, Carlos Andrade Marín Hospital, Quito, Ecuador.

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Ulrich, S., Müller, J., Furian, M., Saxer, S., Schneider, S. R., Herzig, J., Bauer, M., Schmucki, M., Saragoni, D., Mayer, L., Schwarz, E. I., Cajamarca, E., Hoyos, R., & Lichtblau, M. (2026). Effects of a Sea-Level Stay on Pulmonary Hemodynamics in Patients With Pulmonary Arterial Hypertension Living in Quito Near 2,850 m. CHEST, 170(2), 512-523. https://doi.org/10.1016/j.chest.2026.02.043

Vancouver

Ulrich S, Müller J, Furian M, Saxer S, Schneider SR, Herzig J, et al. Effects of a Sea-Level Stay on Pulmonary Hemodynamics in Patients With Pulmonary Arterial Hypertension Living in Quito Near 2,850 m. CHEST. 2026;170(2):512-523. doi:10.1016/j.chest.2026.02.043

BibTeX
@article{Ulrich2026,
  author = {Ulrich, Silvia and Müller, Julian and Furian, Michael and Saxer, Stéphanie and Schneider, Simon R and Herzig, Joel and Bauer, Meret and Schmucki, Mirjam and Saragoni, Diego and Mayer, Laura and Schwarz, Esther I and Cajamarca, Elizabeth and Hoyos, Rodrigo and Lichtblau, Mona},
  title = {Effects of a Sea-Level Stay on Pulmonary Hemodynamics in Patients With Pulmonary Arterial Hypertension Living in Quito Near 2,850 m},
  journal = {CHEST},
  year = {2026},
  volume = {170},
  number = {2},
  pages = {512--523},
  doi = {10.1016/j.chest.2026.02.043}
}
Kostenlos starten →